Axsome Therapeutics, Inc. – Consensus ‘buy’ rating and 46.7% Upside Potential

Broker Ratings
[shareaholic app="share_buttons" id_name="post_below_content"]

Axsome Therapeutics, Inc. which can be found using ticker (AXSM) now have 12 market analysts covering the stock. The analyst consensus now points to a rating of ‘buy’. The range between the high target price and low target price is between 200 and 57 calculating the mean target price we have $111.08. Now with the previous closing price of $75.71 this would indicate that there is a potential upside of 46.7%. The 50 day MA is $68.49 while the 200 day moving average is $62.69. The company has a market capitalization of 3.25B. The current stock price for Coherent Corp. is currently 74.62 USD

The potential market cap would be $4,770,427,789 based on the market consensus.

USD

The company is not paying dividends at this time.

Other points of data to note are a P/E ratio of -, revenue per share of 3.45 and a -37.45% return on assets.

Twitter
LinkedIn
Facebook
Email
Reddit
Telegram
WhatsApp
Pocket
Find more news, interviews, share price & company profile here for:

      Search

      Search